We infused NK-92 cells overexpressing NEDD4L and its three substrates into tumor-bearing Hu-SRC mice to evaluate whether NEDD4L-inhibited ferroptosis improved NK cell antitumor immunity. This evidence concerns the gene SRC and neoplasm.